n this episode of Edison Talks, Edison’s director of research for North America, Maxim Jacobs, has an in-depth discussion with the CEO of Auris Medical, Thomas Meyer. They cover Auris Medical’s development programs for intranasal betahistine for acute vertigo as well as to treat some of the major side effects of antipsychotic medication.